How common are cosmetic procedures really?

The average surgeon fee for breast augmentation in the US is $4,875 according to the American Society of Plastic Surgeons 2024 statistics, but this figure represents only the surgeon's professional fee. Adding facility fees ($1,000 to $3,000), anaesthesia ($500 to $1,500), pre-operative blood work, mammograms, and post-operative compression garments, the all-in cost typically runs $7,000 to $12,000 for saline implants and $9,000 to $15,000 for silicone implants, which carry roughly $1,000 to $1,500 in additional implant cost. Geographic variation is significant: costs in major metropolitan areas (New York, Los Angeles, Miami, San Francisco) tend to run 20 to 40% above the national average per RealSelf 2023 data, while procedures performed in lower-cost states like Texas or Florida outside Miami can run 10 to 20% below. Most patients finance through medical credit products like CareCredit or Cherry, with typical 12 to 24-month interest-free promotional periods. Implant lifespan averages 10 to 15 years per FDA data, meaning total lifetime cost including a likely revision can exceed $20,000. Breast augmentation was the second most common cosmetic surgical procedure in the US in 2024 with roughly 320,000 procedures performed.

The average surgeon fee for liposuction is $4,711 per the American Society of Plastic Surgeons 2024 statistics, with total procedure costs typically ranging $6,000 to $10,000 for a single area and $10,000 to $20,000 for multiple-area "360 lipo" procedures encompassing abdomen, flanks, and back. Abdominal liposuction alone is typically $4,000 to $8,000 all-in including facility and anaesthesia fees. Costs scale with the volume of fat removed (FDA-approved tumescent liposuction caps at 5 litres in outpatient settings, with hospital admission required above that threshold) and the complexity of contouring. High-definition liposuction or VASER liposuction add roughly $2,000 to $4,000 to the base price. Liposuction surpassed breast augmentation as the most common cosmetic surgery procedure globally in 2023, with 2.2 million procedures performed worldwide per ISAPS, a 7.7% year-over-year increase. In the US, ASPS 2024 reported approximately 350,000 liposuction procedures, second only to breast augmentation. Recovery typically requires 2 to 3 weeks before returning to non-strenuous work, with full results visible at 3 to 6 months once swelling resolves.

The evidence strongly suggests yes. The 3.4% annual growth rate in ISAPS global data (rising from 23.4 million procedures in 2018 to 35.1 million in 2023), the rise of accessible non-surgical treatments (now 80%+ of total procedures by volume), and the generational shift in attitudes all point to accelerating normalisation. Pew Research Center 2024 data shows roughly 31% of US adults under 30 say they would consider a cosmetic procedure compared with 16% of those over 65, a cohort effect rather than a lifecycle one given attitudes hold relatively constant within cohorts as they age. ISAPS reports that under-35 patients accounted for approximately 36% of procedures in 2023, up from 30% in 2018. Social media has both increased exposure to altered appearances (a 2021 study in JAMA Dermatology found Instagram users requesting procedures were 2.5 times more likely to cite specific filtered selfies as reference) and destigmatised disclosure: high-profile celebrities like Bella Hadid and Khloe Kardashian openly discussing procedures has reduced the social cost of admission. The South Korean market remains the most normalised, with one in three women aged 19 to 29 reporting cosmetic surgery per Gallup Korea 2020.

Approximately 3% of US adults have had invasive cosmetic surgery, and around 5% have had non-surgical cosmetic treatments such as Botox, fillers, or laser resurfacing, according to Pew Research Center survey data (2023 to 2025). Combined, roughly 8% of US adults have had any cosmetic procedure, a figure that has risen from approximately 5% in 2014. These figures rise sharply with income: people with household incomes over $100,000 are roughly three times more likely to have had a procedure than those under $40,000, reflecting the financial barrier (typical surgical procedures range from $4,000 to $15,000 all-in) rather than a meaningful preference difference. By gender, the gap is wide: ASPS 2024 data shows women account for approximately 92% of all cosmetic procedures, though men's share has risen from 7.4% to 8% over the past decade with the steepest growth in blepharoplasty and rhinoplasty. By age, the 35 to 50 bracket shows the highest cumulative procedure rates, with over 1 in 10 women in that bracket reporting at least one cosmetic procedure per ISAPS 2023. Regionally within the US, California, Florida, Texas, and New York account for the majority of procedures, mirroring population centres but also disproportionate Miami concentration.

The 92% female share reported by ASPS 2024 reflects the asymmetric social pressure placed on women's physical appearance across most cultures. Women's attractiveness is more closely tied to professional and social outcomes per published research: a 2018 Quarterly Journal of Economics paper by Mobius and Rosenblat estimated the "beauty premium" in earnings at approximately 10 to 15% for women versus 4 to 5% for men, while Hamermesh's well-known book Beauty Pays (2011) documents larger lifetime-earnings effects for women in client-facing roles. Women are also more scrutinised by media (a 2017 study in Sex Roles found female celebrities are critiqued for appearance roughly 7 times as often as male celebrities) and more frequently targeted by beauty and anti-ageing marketing, with the global anti-ageing market projected at $93 billion by 2027 (Statista). Male participation is growing fast, with US male procedures rising approximately 30% from 2014 to 2024, but from a very low base. The fastest-growing male procedures (blepharoplasty up 53% per ISAPS, rhinoplasty, gynaecomastia surgery, hair restoration) align with workplace-relevant appearance concerns, consistent with growing research on appearance-based professional consequences for men in client-facing and leadership roles.

Globally, liposuction became the most common cosmetic surgical procedure in 2023, with 2.2 million procedures recorded by ISAPS, overtaking breast augmentation which had held the top position for over a decade. The shift reflects growing demand for body contouring, particularly for "snatched waist" and "BBL" body shapes amplified by social media, alongside the FDA's 2023 black-box warning on textured breast implants which slightly dampened augmentation demand. In the US specifically, breast augmentation and liposuction trade positions year to year, with ASPS 2024 reporting roughly 320,000 augmentations versus 350,000 liposuctions. Eyelid surgery (blepharoplasty, 220,000) ranks third, followed by rhinoplasty (210,000) and abdominoplasty / tummy tuck (160,000). For minimally invasive procedures, botulinum toxin injections (Botox, Dysport, Xeomin, Jeuveau) are by far the most common globally with approximately 9 million procedures in the US in 2024 per ASPS, dwarfing all surgical procedures combined. Hyaluronic acid soft-tissue fillers rank second among non-surgical at roughly 5 million treatments, followed by laser hair removal and chemical peels.

The 35 to 54 age bracket accounts for the largest share of cosmetic surgery patients in the United States, according to ASPS 2024 data. Patients aged 35 to 50 represent approximately 43% of all surgical procedures. The 51 to 64 bracket accounts for a further 29%, with patients over 65 representing around 14%. Patients under 35 account for approximately 14% of surgical procedures, though their share of non-surgical treatments is considerably higher, particularly for neuromodulators and fillers. The age distribution reflects both financial capacity and the lifecycle timing of common aesthetic concerns: sun damage, volume loss, and skin laxity accumulate through the 30s and 40s, creating demand that peaks in that decade.

Botulinum toxin injections (including Botox, Dysport, and Xeomin) are by far the most common minimally invasive cosmetic procedure globally, with ISAPS recording tens of millions of treatments annually. In the US, ASPS 2024 data recorded approximately 9.3 million botulinum toxin procedures, making it the single most common cosmetic treatment by a large margin. Hyaluronic acid fillers (including Juvederm and Restylane) are the second most common non-surgical treatment, with 4.4 million US procedures recorded in 2024. Chemical peels, laser hair removal, and microneedling round out the top five. Non-surgical procedures have grown at a faster rate than surgical procedures over the past decade, driven partly by accessibility and partly by a new generation of patients who are intervening earlier and maintaining results with repeat treatments.

Recovery timelines vary substantially by procedure. Botulinum toxin and filler injections require essentially no downtime, with patients returning to normal activities immediately, though bruising can persist for several days. Rhinoplasty typically involves one to two weeks of visible swelling and bruising, with most social activities resumable at two weeks, though full swelling resolution takes 12 to 18 months. Liposuction recovery depends on the area treated: patients typically return to desk work within a week but avoid exercise for four to six weeks. Facelift recovery involves two weeks of significant bruising and swelling, with most patients comfortable in social situations at three to four weeks. Breast augmentation recovery typically allows return to non-strenuous work within a week, with full recovery and implant settling at three to six months.

Complication rates vary significantly by procedure type, surgeon experience, and facility accreditation. For breast augmentation, ASPS data shows a 10-year revision or reoperation rate of approximately 20 to 25%, driven primarily by capsular contracture (scar tissue hardening around the implant) and implant rupture or exchange. For rhinoplasty, revision rates range from 5 to 15% in published studies, reflecting both the technical complexity of the procedure and high patient expectations for subtle aesthetic outcomes. For minimally invasive procedures, serious complication rates are low: filler-related vascular occlusion occurs in an estimated 1 in 50,000 to 100,000 treatments, though it is a severe when it does. Board certification and accredited facility status are the strongest predictors of lower complication rates across procedure types.

Multiple studies have found a correlation between social media use and interest in cosmetic procedures, though the causal direction is debated. A 2019 survey published in JAMA Facial Plastic Surgery found that 55% of facial plastic surgeons reported seeing patients who wanted to improve their appearance in selfies, up from 13% in 2013. The phenomenon of "Snapchat dysmorphia," coined by researchers to describe patients requesting procedures to resemble their filtered selfie images, was first described in a 2018 paper in JAMA Facial Plastic Surgery. A 2022 study in Aesthetic Surgery Journal found that higher social media consumption was independently associated with both greater interest in cosmetic procedures and more negative body image, with the relationship holding after controlling for age and income. The American Academy of Facial Plastic and Reconstructive Surgery reports that social media is now cited by patients as an influence in approximately one-third of consultations.

Body dysmorphic disorder (BDD), characterised by an obsessive preoccupation with a perceived physical flaw that is minor or undetectable to others, is estimated to affect 2 to 3% of the general population. Among cosmetic surgery patients, studies find BDD prevalence of 7 to 15%, substantially higher than the general population. Patients with BDD consistently report lower satisfaction with cosmetic procedures and higher rates of requesting revision, and the condition can worsen following surgery if the underlying distress is not addressed. The American Society of Plastic Surgeons recommends psychological screening as part of the preoperative consultation process. A 2018 meta-analysis in Aesthetic Plastic Surgery found that BDD was the single strongest predictor of post-operative dissatisfaction across procedure types, making preoperative screening both ethically important and a practical predictor of outcome quality.

ISAPS Global Survey 2023 data shows meaningful regional variation in which procedures are most popular. In North America, breast augmentation and liposuction dominate surgical volume, consistent with the US driving regional trends. In Asia, where skin lightening and eye-widening procedures are culturally prominent, blepharoplasty (eyelid surgery) and rhinoplasty rank among the most common surgical procedures in South Korea, Japan, and China. South Korea has the highest per-capita rate of cosmetic surgery in the world by most estimates, with procedures per 1,000 population significantly exceeding other major markets. In Brazil, liposuction, breast augmentation, and abdominoplasty dominate, with the country ranking second globally in total procedure volume after the United States. These regional patterns reflect both cultural beauty ideals and the structure of local healthcare markets.

Psychological outcome research on cosmetic surgery shows broadly positive results for patients without pre-existing body image disorders. A meta-analysis by Dreher et al. (2016) covering 37 studies and over 4,000 patients found that cosmetic surgery was associated with improved body image, quality of life, and self-esteem in the majority of patients at follow-up assessments of six months to two years. Breast augmentation patients showed some of the strongest positive psychological outcomes in the literature. However, patients with BDD, depression, or unrealistic expectations showed significantly worse outcomes, and a subset of patients (approximately 5 to 10% in larger studies) reported that surgery had not met their expectations or had created new concerns. These findings underline why psychological assessment and expectation management during consultation are considered best practice by plastic surgery professional bodies.

Liposuction in the US averages $3,600 to $7,000 for a single area (ASPS 2023 data). Multiple-area procedures run $6,000 to $15,000. The total cost includes the surgeon's fee, anaesthesia, facility fees, and compression garments. Liposuction is not covered by insurance as it is a cosmetic procedure. Prices vary significantly by city: New York and Los Angeles typically run 20 to 40% above the national average. SmartLipo and laser-assisted variants cost slightly more than traditional tumescent liposuction. Results are permanent in the treated area, though weight gain can redistribute to untreated areas.

A full abdominoplasty (tummy tuck) typically costs $8,000 to $15,000 in the US, including surgeon's fee, anaesthesia, and facility costs. Mini abdominoplasty, which addresses only the area below the navel, costs $5,000 to $8,000. Insurance does not cover cosmetic tummy tucks, though a panniculectomy (removal of a hanging skin apron) may be partially covered if it causes chronic infections or skin conditions. Tummy tucks are among the most requested procedures after significant weight loss or pregnancy and are frequently combined with liposuction as part of a body contouring procedure.

Rhinoplasty in the US averages $7,000 to $15,000 (ASPS 2023). The range reflects the complexity of the procedure: a tip refinement is at the lower end; a full structural rhinoplasty addressing both form and function is at the higher end. Revision rhinoplasty (correcting a previous nose job) typically costs more than primary surgery due to the additional complexity. Functional rhinoplasty to correct breathing problems may be partially covered by insurance; cosmetic rhinoplasty is not. Recovery involves swelling for 2 to 3 weeks and full results typically visible at 12 months.

Sono Bello is a US laser body contouring chain offering TriSculpt laser liposuction. Reported costs range from $1,395 to $3,500 per area, lower than traditional liposuction in part because Sono Bello performs procedures under local anaesthesia in an outpatient setting rather than a hospital or surgical centre. Total costs for multi-area treatments typically run $4,000 to $10,000. Prices are not published on their website and are provided at consultation. Consumer reviews on cost transparency and outcomes are mixed: research the specific location and surgeon credentials before booking, as outcomes vary significantly between practitioners.

Hyaluronic acid lip fillers (Juvederm, Restylane, and similar) typically last 6 to 12 months. Lips metabolise filler faster than most other facial areas due to the high movement. First-time treatments often last at the shorter end; repeat treatments may last longer as scar tissue builds. Results also depend on the specific product used: thicker, more cross-linked formulations last longer. Dissolving lip filler with hyaluronidase is straightforward and widely available if results are unsatisfactory. Average cost in the US is $600 to $1,000 per syringe; most lip treatments require one syringe.